BNGO Stock Forecast: BioNano Genomics Inc set to crash after offering shares at 35% below close price

  • NASDAQ: BNGO is set to reverse its gains and crash after announcing a fresh public offering.
  • BioNano Genomics may be trying to cash on the recent massive rally. 
  • The firm's genetic breakthrough may allow it to recover once the dust settles. 

The company giveth, the company taketh away – BioNano Genomics (NASDAQ: BNGO) shares are set to suffer on Wednesday, reversing a substantial portion of its gains. Premarket trading figures are pointing to a drop of roughly 20% to $7.27 from the previous close at $9.14. It can get substantially worse. 

The San Diego-based genetics firm has announced it is offering new shares at only $6. Does management value the company's worth some 35% below what investors are willing to pay? Is BioNano in dire economic straits, forcing a firesale? 

These questions and others may compound the damage inflicted on NASDAQ: BNGO as investors digest the news on the day that Joe Biden is inaugurated as US President. The incoming administration is emphasizing the role of science in society and may channel funds to Research and Development – that may benefit BionNano. 

BNGO stock price

Apart from a Biden boost, will NASDAQ: BNGO rise despite the low pricing? It is essential to note that this is not the first time such news is floated. Earlier this year, reports of issuance sent shares below $5, and now the firm is worth much more. Can it swiftly recover? 

The answer depends mostly on BioNano's products – all related to genetic treatment. The company announced progress in several fields, from the autism spectrum, identifying reasons for severe COVID-19 illness and cancer treatments. Upbeat news on what the company produces and discovers could prove more significant than financial developments. Neverteless, shares will likely suffer badly before attempting a recovery. 

More Best Stocks to Buy Forecast 2021: Vaccines and zero rates to broaden recovery

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

Are you new to trading or have been trading for a while and you feel stuck?

Try with us!
Become Premium!

Latest Forex News

Latest Forex News

Editors’ Picks

EUR/USD holds above 1.22 as the dollar slides across the board

EUR/USD has extended its gains and has topped 1.22, the highest since February. The safe-haven dollar is weakening amid the risk-on mood and as the Fed sticks to its dovish policy. US housing figures were mixed. The Fed's Bostic is set to speak later. 


GBP/USD extends corrective slide below 1.4200

GBP/USD trades around 1.4180, retreating from 1.4219, the highest since February. Britain's unemployment rate surprisingly dropped to 4.8% as the reopening continues. The dollar is on the back foot amid the upbeat market mood.


XAU/USD consolidates below $1870 amid risk-on mood

Gold price has entered a phase of upside consolidation, having faced rejection once again above $1870. The gold price looks unimpressed by the latest leg down in the US dollar, amid dovish Fed expectations.

Gold News

SEC attempts to block XRP holders from presenting evidence in Ripple case

The Securities & Exchange Commission filed another objection to the motion to intervene by XRP holders. The government agency argues that allowing third-party defendants into the case would “sow chaos” into the litigation.

Read more

Coinbase reveals intention to raise $1.25 billion following direct listing

Since its debut on the Nasdaq, Coinbase’s share price has merely collapsed. Given the recent weakness in its stock price, the leading cryptocurrency exchange is looking for a further cash injection. 

Read more